Panoff Marc L

Senior Vice President, FinanceLB PHARMACEUTICALS INC (LBRX) · full profile →Form 4 · filed Sep 29, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
0 non-derivative · 11 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 10, 2025Grant(A)4K4K
Sep 10, 2025Disposed to issuer(D)8960
Sep 10, 2025Grant(A)896896
Sep 10, 2025Disposed to issuer(D)1K0
Sep 10, 2025Grant(A)1K1K
Sep 10, 2025Grant(A)14K14K
Sep 10, 2025Disposed to issuer(D)7K0
Sep 10, 2025Grant(A)7K7K
Sep 10, 2025Grant(A)91K$091K
Sep 10, 2025Disposed to issuer(D)4K0
Sep 10, 2025Disposed to issuer(D)14K0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001304340-25-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly: